U.S. Investment Bank Tried to Sell Teva Division Without Company's Knowledge

Firm's effort was spurred by rumors at a pharmaceutical convention in San Francisco in January that Teva was planning on partially divesting.

Teva CEO Jeremy Levin probably opened his conversation on Sunday night with a U.S.-based official from Jefferies, an investment banking firm, something...